sec filing
NV
NASDAQ · NVCT
Nuvectis Pharma, Inc.
Healthcare · Biotechnology
$21.87
Down-$1.37 (-6.24%)
Updated Sep 17, 2026, 7:39 PM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 192.83M
- P/E ratio
- -7.29
- Dividend yield
- 0.00%
- 52-week range
- $7.17 – $29.28
- Volume
- 136.42K
- Avg. volume
- 105.27K
Price performance
NVCT price history
1M range · 20 trading sessions · Daily adjusted prices
NVCT closed at $21.87 after 20 trading sessions, down 6.26% for the selected period.
- Last close
- $21.87
- Period change
- -6.26%
- Period low
- $21.87
- Period high
- $25.89
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $21.84 | $22.41 | $21.31 | $21.87 | 136.42K |
| Sep 15, 2026 | $23.00 | $23.01 | $21.78 | $21.92 | 166.14K |
| Sep 14, 2026 | $23.25 | $24.12 | $22.79 | $23.35 | 203.43K |
| Sep 11, 2026 | $22.96 | $24.24 | $22.28 | $23.99 | 221.08K |
| Sep 10, 2026 | $22.09 | $23.02 | $22.01 | $22.49 | 107.05K |
| Sep 9, 2026 | $23.89 | $24.5399 | $22.67 | $22.78 | 165.63K |
| Sep 8, 2026 | $24.00 | $24.6897 | $22.73 | $23.99 | 136.31K |
| Sep 4, 2026 | $24.00 | $25.19 | $23.96 | $24.49 | 117.17K |
| Sep 3, 2026 | $24.00 | $24.62 | $22.82 | $24.37 | 135.97K |
| Sep 2, 2026 | $23.06 | $24.01 | $23.06 | $23.92 | 188.61K |
| Sep 1, 2026 | $22.80 | $23.81 | $22.77 | $23.06 | 176.93K |
| Aug 31, 2026 | $23.52 | $24.35 | $22.57 | $22.73 | 192.57K |
| Aug 28, 2026 | $24.93 | $25.65 | $23.29 | $23.73 | 137.2K |
| Aug 27, 2026 | $25.03 | $25.84 | $24.35 | $25.19 | 319.9K |
| Aug 26, 2026 | $25.80 | $25.80 | $23.84 | $25.00 | 362.89K |
| Aug 25, 2026 | $23.90 | $25.9399 | $23.85 | $25.89 | 276.63K |
| Aug 24, 2026 | $23.56 | $24.55 | $23.335 | $23.87 | 231.13K |
| Aug 21, 2026 | $23.59 | $23.9299 | $22.83 | $23.56 | 196.98K |
| Aug 20, 2026 | $22.98 | $23.99 | $22.36 | $23.35 | 230.01K |
| Aug 19, 2026 | $21.44 | $23.74 | $21.00 | $23.33 | 362.93K |
Latest NVCT news
The latest Smart Investors Daily articles mentioning NVCT.
Stock researchResearch & News · SEC Filings
Loading stock research…